Sangamo Therapeutics Inc (NASDAQ:SGMO)

Delayed Data
As of Mar 23
 -0.40 / -1.81%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Sangamo Therapeutics Inc have a median target of 20.00, with a high estimate of 30.00 and a low estimate of 6.00. The median estimate represents a -8.05% decrease from the last price of 21.75.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Sangamo Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -48.33%
Growthannually 90.71%


Growthquarterly -33.64%
Growthannually 174.48%
Key to the earnings and sales forecast charts.